Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
boston blog main
clinical trials
medical device
national blog main
san francisco blog main
san francisco top stories
biotech ipos
boston top stories
cancer
generic drugs
investing
national
national top stories
new york blog main
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
10x genomics
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
baker brothers
bioinnovation capital
biolabs
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer diagnostics
cancer immunotherapy
cancer vaccine
What
life
4
×
public
4
×
ipo
science
biotech
companies
firms
haul
sciences
week
biotechs
blood
boost
broader
cancer
club
company
continued
crop
detect
developing
driving
drug
exceeded
files
followed
genomics
good
grail
group
healthcare
history
improved
industry
innovation
innovations
intended
investment
investors
join
Language
unset
Current search:
public
×
biotech
×
life
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M